With nearly twenty years of experience in non-clinical evaluation of ophthalmic drugs, the Evaluation of Ophthalmic Drugs has so far emerged as a first-class non-clinical ophthalmology business division in China. It boasts a team of experienced professionals in ophthalmology and possesses complete, internationally-advanced ophthalmic testing and surgical operation instruments.
The division has conducted a number of non-clinical studies of ophthalmic drugs of diverse dosage forms (e.g., eye drop, intravitreous injections, subretinal injections, suprachoroidal injections, extended-release agents, ocular implants, intraocular irrigating solutions, etc.). One of its representative marketed drug is conbercept®.